Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

LLY

Lilly(Eli) & Co

Feb 11 • 04:00PM ET

1,015.21

-9.79 -0.96 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: NVO JNJ ABBV MRK AZN-D AMGN PFE SNY BMY GSK

| Held by: VTI VOO IVV SPY VUG XLV VIG IWF VHT IVW

Index	S&P 500	P/E	44.23	EPS (ttm)	22.96	Insider Own	9.93%	Shs Outstand	945.38M	Perf Week	-8.30%
Market Cap	959.76B	Forward P/E	24.57	EPS next Y	41.33	Insider Trans	-3.93%	Shs Float	851.51M	Perf Month	-6.09%
Enterprise Value	992.41B	PEG	0.93	EPS next Q	7.21	Inst Own	73.47%	Short Float	0.82%	Perf Quarter	5.02%
Income	20.64B	P/S	14.73	EPS this Y	39.72%	Inst Trans	-0.71%	Short Ratio	2.04	Perf Half Y	58.77%
Sales	65.18B	P/B	40.36	EPS next Y	22.17%	ROA	19.33%	Short Interest	6.98M	Perf YTD	-5.53%
Book/sh	25.16	P/C	96.81	EPS next 5Y	26.53%	ROE	96.82%	52W High	1133.95 -10.47%	Perf Year	17.37%
Cash/sh	10.49	P/FCF	103.51	EPS past 3/5Y	49.25% 27.59%	ROIC	31.91%	52W Low	623.78 62.75%	Perf 3Y	194.16%
Dividend Est.	6.74 (0.66%)	EV/EBITDA	35.08	Sales past 3/5Y	31.69% 21.58%	Gross Margin	85.40%	Volatility	4.09% 3.32%	Perf 5Y	401.14%
Dividend TTM	6.00 (0.59%)	EV/Sales	15.23	EPS Y/Y TTM	120.94%	Oper. Margin	45.56%	ATR (14)	40.73	Perf 10Y	1321.46%
Dividend Ex-Date	Feb 13, 2026	Quick Ratio	1.24	Sales Y/Y TTM	44.70%	Profit Margin	31.66%	RSI (14)	45.29	Recom	1.53
Dividend Gr. 3/5Y	15.24% 15.18%	Current Ratio	1.55	EPS Q/Q	58.78%	SMA20	-2.95%	Beta	0.40	Target Price	1236.73
Payout	26.14%	Debt/Eq	1.79	Sales Q/Q	42.56%	SMA50	-3.35%	Rel Volume	0.76	Prev Close	1025.00
Employees	47000	LT Debt/Eq	1.72	Earnings	Feb 04 BMO	SMA200	17.77%	Avg Volume	3.42M	Price	1015.21
IPO	Jul 09, 1970	Option/Short	Yes / Yes	EPS/Sales Surpr.	9.10% 7.51%	Trades		Volume	2,595,821	Change	-0.96%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-26	Resumed	UBS	Buy	$1250
Dec-16-25	Upgrade	Daiwa Securities	Neutral → Buy	$1230
Dec-15-25	Reiterated	Goldman	Buy	$951 → $1145
Dec-15-25	Reiterated	BofA Securities	Buy	$1286 → $1268
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$1165
Nov-10-25	Upgrade	Leerink Partners	Market Perform → Outperform	$1104
Oct-20-25	Reiterated	BMO Capital Markets	Outperform	$840 → $930
Oct-14-25	Upgrade	Erste Group	Hold → Buy
Sep-17-25	Downgrade	Berenberg	Buy → Hold	$830
Aug-27-25	Upgrade	HSBC Securities	Reduce → Hold	$700
Aug-18-25	Downgrade	Daiwa Securities	Outperform → Neutral	$700
Aug-07-25	Downgrade	Leerink Partners	Outperform → Market Perform	$715
Jun-05-25	Downgrade	Erste Group	Buy → Hold
Apr-28-25	Downgrade	HSBC Securities	Buy → Reduce	$1150 → $700
Apr-22-25	Initiated	Cantor Fitzgerald	Overweight	$975
Dec-10-24	Resumed	BofA Securities	Buy	$997
Nov-15-24	Initiated	Wolfe Research	Outperform	$1000
Oct-17-24	Initiated	Bernstein	Outperform	$1100
Sep-13-24	Resumed	Citigroup	Buy	$1060
Aug-12-24	Upgrade	Deutsche Bank	Hold → Buy	$1025

Show Previous Ratings

Today 08:39PM	Inspire Medical Systems Q4 Earnings Call Highlights (MarketBeat)
07:38PM	Eli Lilly and Company (LLY) to Acquire Orna Therapeutics in $2.4B Deal to Expand RNA Pipeline (Insider Monkey)
06:00PM	PRIMECAP Management's Strategic Moves: A Closer Look at Eli Lilly and Co (GuruFocus.com)
04:14PM	Top Analyst Reports for Eli Lilly, Marriott & Fortinet (Zacks)
02:26PM	Robust Demand for Eli Lilly and Company (LLY)'s Obesity and Diabetes Treatments Drives Strong Investor Sentiment (Insider Monkey)
12:57PM	Loading…
12:57PM	Pharma companies left out of Trump's drug-pricing deals look for way in (Reuters)
09:54AM	Is Novo Nordisk's Turnaround Story at Risk After Weak 2026 Outlook? (Zacks)
08:59AM	Taking the new Wegovy pill every day is really complicated. Will patients stick with it? (MarketWatch)
01:48AM	Analyst Report: Incyte Corporation (Morningstar Research)
12:41AM	The Top 5 Analyst Questions From Eli Lilly's Q4 Earnings Call (StockStory)
Feb-10-26 04:51PM	Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. (Barrons.com)
04:01PM	Gilead's Earnings Surprise. HIV Drug Sales Were Strong. (Barrons.com)
03:48PM	Taking the new Wegovy pill every day is really complicated. Will patients stick with it? (MarketWatch)
11:10AM	LLY Expands Cell Therapy Ambitions With $2.4B Orna Therapeutics Deal (Zacks)
10:49AM	Eli Lilly's 2025 Surge Sets the Stage for Another Big Year in 2026 (Zacks)
10:38AM	Loading…
10:38AM	INCY Q4 Earnings Miss Estimates, Revenues Beat on Higher Product Sales (Zacks)
07:13AM	Nektar, continuing comeback, says eczema drugs effects hold up in follow-up study (BioPharma Dive)
12:01AM	Novo Nordisk Launches Suit to Knock Out Hims & Hers Weight Loss Knockoffs (The Daily Upside)
Feb-09-26 03:13PM	Eli Lilly to Buy Cell Therapy Company Orna for $2.4 Billion (Barrons.com)
02:19PM	Novo Nordisk Escalates Fight Against Hims & Hers (The Wall Street Journal)
01:19PM	Eli Lilly to Buy Biotech Orna Therapeutics for Up to $2.4 Billion (The Wall Street Journal)
01:00PM	Eli Lilly bets on in vivo cell therapy in $2.4bn Orna Therapeutics buyout (Pharmaceutical Technology)
12:28PM	Super Bowl Commercials 2026: Complete List Of Ads, The Companies Behind Them And Who Won Over Fans (Benzinga)
11:25AM	Novo sues Hims & Hers despite Wegovy pill offering U-turn (Pharmaceutical Technology)
10:49AM	Hims & Hers stock crashes after FDA announces plans to take 'decisive steps' against GLP-1 compounds (Yahoo Finance)
10:24AM	Hims & Hers Plummets On FDA Crackdown, Novo Nordisk Lawsuit (Investor's Business Daily)
10:12AM	Hims & Hers Halts Knockoff Wegovy Pill After Just Two Days: Here's Why (Investor's Business Daily)
09:55AM	Novo Nordisk Stock Whipsawed by GLP-1 Pill Fears: Relief Ahead? (Zacks)
09:37AM	Novo Nordisk Stock Soars After Hims & Hers Scraps Copycat Weight-Loss Pill (The Wall Street Journal)
09:28AM	Eli Lilly buys Orna, Novo Nordisk sues Hims & Hers, Kyndryl plunges (Yahoo Finance Video)
09:15AM	Loading…
09:15AM	Unlocking Lilly (LLY) International Revenues: Trends, Surprises, and Prospects (Zacks)
09:11AM	Eli Lilly Bets $2.4 Billion On Small Biotech To Boost Future Cell Treatments (Benzinga)
09:11AM	Should You Buy, Sell or Hold Pfizer Stock After a Lukewarm Q4? (Zacks)
09:00AM	Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:12AM	Hims & Hers Stock Plunges. Its Weight Loss Drug Strategy Backfired. (Barrons.com)
07:29AM	Eli Lilly Pays $350 Million Upfront in China Biotech Collaboration Deal (GuruFocus.com)
07:18AM	Eli Lilly Stock Rises. It's Acquiring This Cell Therapy Company for $2.4 Billion. (Barrons.com)
07:09AM	Lilly to buy Orna Therapeutics for up to $2.4 billion (Reuters)
07:00AM	Lilly to acquire Orna Therapeutics to advance cell therapies (PR Newswire)
06:42AM	Lilly Deepens Longtime Innovent Partnership (GuruFocus.com)
06:01AM	Innovent and Lilly to advance new oncology and immunology medicines (Pharmaceutical Technology)
02:45AM	Novo Nordisk shares rise as Hims abandons $49 weight-loss pill (Reuters)
12:57AM	Innovent Biologics Strikes Partnership Deal With Eli Lilly (The Wall Street Journal)
Feb-08-26 01:31PM	Eli Lilly (LLY) is "the Great Drug Company on Earth," Says Jim Cramer (Insider Monkey)
10:26AM	Analysts Project Eli Lilly (LLY) to Deliver 21%+ Revenue Growth and 40%+ Adjusted Earnings Growth in 2026 (Insider Monkey)
Feb-07-26 05:22PM	Hims & Hers Health Stops Offering Knockoff Wegovy Pill Amid FDA Crackdown (Investor's Business Daily)
08:33AM	Goldman Sachs Reaffirms Buy on Eli Lilly and Company (LLY), Citing 25% Growth Outlook (Insider Monkey)
05:30AM	The Weight-Loss Price Wars Are Breaking Big Pharma's Business Model (The Wall Street Journal)
12:56AM	Jim Cramer Says "Eli Lilly's Constantly Taking Share From Danish Novo Nordisk" (Insider Monkey)
Feb-06-26 05:45PM	Eli Lilly Booms, Then Busts: Stellar Guidance vs Hims Undercut (MarketBeat)
05:13PM	TrumpRx Is Here. Most People Won't Benefit. (Barrons.com)
04:13PM	Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More Stock Market Movers (Barrons.com)
01:52PM	CVS Caremark Replaces Amgen And Eli Lilly's Branded Drugs, Expands Biosimilar Strategy For Weak Bone Disorder (Benzinga)
12:53PM	Big-Name Earnings, Selloffs Highlight Busy Week on Wall Street (Schaeffer's Research)
12:38PM	These Stocks Are Todays Movers: Amazon, Strategy, Robinhood, Novo Nordisk, Molina, Stellantis, Hub Group, and More (Barrons.com)
11:58AM	TrumpRx launches to slash drug prices for cash-paying US patients (Pharmaceutical Technology)
11:52AM	Hims & Hers Stock Drops. It May Be Losing Its Weight-Loss Battle With Novo. (Barrons.com)
11:27AM	Stock Market Divided With S&P 500, Nasdaq Below Key Levels; Google, Amazon AI Spending Stuns: Weekly Review (Investor's Business Daily)
11:06AM	Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push (Zacks)
10:29AM	Eli Lilly Stock Jumps on Wave of Analysts Upgrade (GuruFocus.com)
09:45AM	Eli Lilly (LLY) is a Top-Ranked Growth Stock: Should You Buy? (Zacks)
09:27AM	NVO, LLY Stocks Slide as HIMS Launches $49 Compounded Semaglutide Pill (Zacks)
08:23AM	Incyte Gears Up to Report Q4 Earnings: Is a Beat in the Cards? (Zacks)
08:00AM	China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse. (Investor's Business Daily)
07:52AM	Novos Stratospheric Rise Has Turned Into a $460 Billion Wipeout (Bloomberg)
07:50AM	Multiple Tailwinds Lifted Eli Lilly and Company (LLY) in Q4 (Insider Monkey)
07:04AM	Novo Stock Jumps, Hims & Hers Tanks. This Could Shift the Weight-Loss Copycat Battle. (Barrons.com)
06:47AM	Amazon Defies AI Fears With Huge Spending. Why It's a Big Risk for Markets. (Barrons.com)
05:32AM	US equity fund inflows ease as tech selloff weighs (Reuters)
12:13AM	Trump Says People Will 'Save A Lot Of Money And Be Healthy' With Launch Of TrumpRx Website - But Will It Actually Fill Prescriptions? (Benzinga)
Feb-05-26 11:33PM	Walmarts $1T valuation: A bet on high-income shoppers (TheStreet) -7.79%
09:17PM	Trump launches TrumpRX website offering discounted prescription drugs (Investing.com)
08:24PM	White House Debuts Drug-Buying Site TrumpRx, With Roughly 40 Medications (The Wall Street Journal)
07:52PM	Hims Launches Oral Wegovy Knockoff, But The FDA Could Prove To Be A Problem (Investor's Business Daily)
05:22PM	Pfizer Pops on Q4 Results-But This May Be the Catalyst That Matters Most (MarketBeat)
04:17PM	TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. (MarketWatch)
04:11PM	Hims & Hers Launches New Pill That Sends Shockwaves Across Weight-Loss Drugmakers' Stocks (Investopedia)
04:08PM	Hims offers cheapest GLP-1 weight-loss pill in US in a shock to Novo, Lilly (Reuters)
01:49PM	Lilly stops development of three drugs, including gene therapy (Clinical Trials Arena)
01:44PM	Eli Lilly's 2026 Outlook Push Back Demand Fears: Analyst (Benzinga)
01:15PM	Hims & Hers offers cheaper weight-loss pill in a shock to Novo (Reuters Videos)
11:56AM	Why Eli Lilly (LLY) Shares Are Getting Obliterated Today (StockStory)
11:56AM	Hims & Hers Is Introducing a Cheaper Wegovy Copycat. Novo Nordisk Stock Falls. (Barrons.com)
09:55AM	This Medical Technology Leader Sees Growth Into The 2040s (Investor's Business Daily)
09:51AM	Hims Is Already Knocking Off Novo's Wegovy Pill - For Just $49 A Month (Investor's Business Daily)
09:36AM	Hims stock surges as Wegovy pill copy offered at $49, Novo shares fall (Investing.com)
09:34AM	The Metabolic Split: Why Eli Lilly Soars as Novo Stumbles (MarketBeat)
09:00AM	Morning Movers: Eli Lilly rises, Boston Scientific falls after quarterly results (TipRanks)
08:21AM	The Week Ahead: Inflation Data Hits Amid Earnings Season (Schaeffer's Research)
07:58AM	Rapid Innovation is Reshaping Oncology: Stocks in Focus (Zacks)
03:26AM	Eli Lilly and Company Q4 Earnings Call Highlights (MarketBeat)
02:28AM	Eli Lilly (LLY) Skyrockets as Profits Soar 95% (Insider Monkey)
12:38AM	LLY Q4 Deep Dive: Obesity Medicines, Pipeline Progress, and Market Expansion Drive Outperformance (StockStory)
Feb-04-26 10:38PM	Why Eli Lilly Stock Soared Today (Motley Fool) +10.33%
06:44PM	Patient preference is leaning towards Eli Lilly's weight loss drugs, says Guggenheim's Fernandez (CNBC TV)
05:39PM	Dow Jones Futures: Google Lifts Ailing Techs Late On Strong Earnings, Huge AI Spending (Investor's Business Daily)
05:28PM	Stocks to Watch Wednesday Recap: AMD, Super Micro, Chipotle (The Wall Street Journal)
04:41PM	These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More (Barrons.com)
04:33PM	Analyst Report: Eli Lilly and Company (Morningstar Research)
04:21PM	Eli Lilly Stock Soars While Novo Nordisk SinksWhy the Weight-Loss Leaders Are Headed in Opposite Directions (Investopedia)

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Feb 01 '26	Option Exercise	0.00	3,394	0	29,654	Feb 03 04:32 PM
Skovronsky Daniel	EVP, CS&PO & Pres. LRL	Feb 01 '26	Option Exercise	0.00	12,684	0	150,165	Feb 03 04:31 PM
Van Naarden Jacob	EVP,Pres LLY Oncology&HdCorpBD	Feb 01 '26	Option Exercise	0.00	4,108	0	24,670	Feb 03 04:31 PM
Ricks David A	President, Chair, and CEO	Feb 01 '26	Option Exercise	0.00	31,932	0	547,098	Feb 03 04:29 PM
Rau Diogo	EVP & CIDO	Feb 01 '26	Option Exercise	0.00	3,752	0	23,471	Feb 03 04:28 PM
Jonsson Patrik	EVP & President, LLY Int'l	Feb 01 '26	Option Exercise	0.00	3,930	0	57,581	Feb 03 04:27 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Feb 01 '26	Option Exercise	0.00	3,572	0	43,303	Feb 03 04:26 PM
Hakim Anat	EVP, GC & Secretary	Feb 01 '26	Option Exercise	0.00	6,700	0	17,662	Feb 03 04:25 PM
Dozier Eric	EVP, Chief People Officer	Feb 01 '26	Option Exercise	0.00	2,858	0	12,697	Feb 03 04:24 PM
LILLY ENDOWMENT INC	10% Owner	Jan 07 '26	Sale	1103.48	292,148	322,380,730	91,896,978	Jan 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jan 05 '26	Sale	1085.01	1,390	1,508,165	92,189,126	Jan 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 29 '25	Sale	1085.04	3,593	3,898,531	92,190,516	Dec 30 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Dec 24 '25	Sale	1085.17	2,629	2,852,920	92,194,109	Dec 29 04:05 PM
LILLY ENDOWMENT INC	10% Owner	Dec 23 '25	Sale	1085.04	240	260,409	92,196,738	Dec 29 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Dec 23 '25	Proposed Sale	1076.48	300,000	322,944,000		Dec 23 12:52 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1109.30	15,632	17,340,625	92,196,978	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 25 '25	Sale	1095.35	147,061	161,082,640	92,212,610	Nov 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 24 '25	Sale	1068.52	142,307	152,058,091	92,359,671	Nov 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 21 '25	Sale	1058.66	105,326	111,504,098	92,501,978	Nov 24 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 24 '25	Proposed Sale	1059.70	305,000	323,208,500		Nov 24 03:01 PM
LILLY ENDOWMENT INC	10% Owner	Nov 20 '25	Sale	1051.66	37,148	39,067,117	92,607,304	Nov 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 19 '25	Sale	1051.17	167,526	176,098,702	92,644,452	Nov 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 18 '25	Sale	1034.78	60,213	62,306,969	92,811,978	Nov 19 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 19 '25	Proposed Sale	1030.05	310,000	319,315,500		Nov 19 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Nov 17 '25	Sale	1030.68	9,886	10,189,269	92,872,191	Nov 18 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 14 '25	Sale	1030.87	178,295	183,799,044	92,882,077	Nov 17 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 13 '25	Sale	1030.26	46,606	48,016,098	93,060,372	Nov 14 04:00 PM
Zakrowski Donald A	SVP, Finance, & CAO	Nov 13 '25	Sale	1010.50	1,000	1,010,500	2,840	Nov 13 04:14 PM
LILLY ENDOWMENT INC	10% Owner	Nov 12 '25	Sale	1011.18	305,000	308,411,204	93,106,978	Nov 13 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 13 '25	Proposed Sale	1017.78	295,000	300,245,100		Nov 13 03:02 PM
LILLY ENDOWMENT INC	10% Owner	Nov 11 '25	Sale	986.64	283,131	279,347,680	93,411,978	Nov 12 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 10 '25	Sale	972.52	16,869	16,405,396	93,695,109	Nov 12 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 12 '25	Proposed Sale	988.62	305,000	301,529,100		Nov 12 03:15 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 10 '25	Proposed Sale	924.37	300,000	277,311,000		Nov 10 03:11 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	951.56	40,432	38,473,442	93,711,978	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 05 '25	Sale	933.26	179,042	167,092,104	93,752,410	Nov 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 04 '25	Sale	910.72	526	479,038	93,931,452	Nov 05 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Nov 03 '25	Sale	888.83	300,000	266,648,921	93,931,978	Nov 04 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 04 '25	Proposed Sale	896.53	220,000	197,236,600		Nov 04 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Oct 31 '25	Sale	863.35	301,342	260,165,031	94,231,978	Nov 03 04:00 PM
LILLY ENDOWMENT, INC.	10% Owner	Nov 03 '25	Proposed Sale	862.86	300,000	258,858,000		Nov 03 03:06 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Sale	863.24	3,658	3,157,722	94,533,320	Oct 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 09 '25	Sale	852.49	10,602	9,038,055	94,536,978	Oct 10 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 10 '25	Proposed Sale	855.35	305,000	260,881,750		Oct 10 02:57 PM
LILLY ENDOWMENT INC	10% Owner	Oct 08 '25	Sale	850.27	101,420	86,234,874	94,547,580	Oct 09 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 07 '25	Sale	848.01	26,795	22,722,401	94,649,000	Oct 08 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Sale	850.22	161,183	137,041,657	94,675,795	Oct 07 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 03 '25	Sale	837.93	192,404	161,220,401	94,836,978	Oct 06 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 06 '25	Proposed Sale	839.87	300,000	251,961,000		Oct 06 03:35 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Sale	821.55	112,596	92,503,361	95,029,382	Oct 03 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	821.47	215,822	177,290,448	95,141,978	Oct 02 04:56 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Sale	794.15	135,193	107,363,016	95,357,800	Oct 02 04:55 PM
LILLY ENDOWMENT INC	10% Owner	Oct 02 '25	Proposed Sale	825.42	305,000	251,753,100		Oct 02 03:20 PM
LILLY ENDOWMENT INC	10% Owner	Oct 01 '25	Proposed Sale	763.00	295,000	225,085,000		Oct 01 04:08 PM
LILLY ENDOWMENT INC	10% Owner	Sep 30 '25	Sale	763.39	113,694	86,793,274	95,492,993	Oct 01 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 19 '25	Sale	763.10	23,665	18,058,643	95,606,687	Sep 22 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Sale	764.65	106,626	81,531,959	95,630,352	Sep 19 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Sep 18 '25	Proposed Sale	760.13	300,000	228,039,000		Sep 18 03:04 PM
DONALD ZAKROWSKI	Officer	Aug 28 '25	Proposed Sale	734.17	2,000	1,468,340		Aug 28 04:19 PM
Zakrowski Donald A	SVP, Finance, & CAO	Aug 28 '25	Sale	734.93	1,000	734,930	3,840	Aug 28 04:14 PM
Montarce Lucas	EVP & CFO	Aug 15 '25	Buy	691.79	715	494,627	14,685	Aug 15 04:13 PM
Alvarez Ralph	Director	Aug 13 '25	Buy	660.25	758	500,473	758	Aug 14 04:12 PM
Van Naarden Jacob	EVP & Pres., Lilly Oncology	Aug 13 '25	Buy	647.36	1,000	647,360	20,562	Aug 13 04:15 PM
Ricks David A	President, Chair, and CEO	Aug 12 '25	Buy	644.77	1,632	1,052,263	546,601	Aug 12 04:23 PM
Skovronsky Daniel	EVP, CSO & Pres. LRL & LLY Imm	Aug 12 '25	Buy	634.40	1,000	634,405	137,660	Aug 12 04:20 PM
Sulzberger Gabrielle	Director	Aug 12 '25	Buy	641.18	117	75,018	2,703	Aug 12 04:19 PM
Fyrwald J Erik	Director	Aug 12 '25	Buy	642.33	1,565	1,005,242	74,578	Aug 12 04:17 PM
Yuffa Ilya	EVP&Pres, LLY USA&Global Capab	Aug 11 '25	Sale	627.01	1,250	783,762	26,260	Aug 12 04:16 PM
JACKSON JAMERE	Director	Aug 08 '25	Buy	639.56	200	127,913	9,402	Aug 08 04:20 PM
Seymour Melissa	EVP, Global Quality	Aug 01 '25	Option Exercise	0.00	952	0	952	Aug 04 04:16 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Sale	805.07	280,000	225,419,259	95,736,978	Jul 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Jul 24 '25	Proposed Sale	798.89	280,000	223,689,200		Jul 24 03:01 PM
Zakrowski Donald A	SVP, Finance, & CAO	May 27 '25	Sale	716.41	1,000	716,410	4,840	May 27 04:13 PM
Yuffa Ilya	EVP & President, LLY Int'l	May 14 '25	Sale	749.24	1,250	936,550	27,510	May 15 04:17 PM
Yuffa Ilya	Officer	May 14 '25	Proposed Sale	749.24	2,500	1,873,100		May 14 12:25 PM
DONALD ZAKROWSKI	Officer	Mar 13 '25	Proposed Sale	821.86	2,000	1,643,720		Mar 13 04:57 PM
Zakrowski Donald A	SVP, Finance, & CAO	Mar 13 '25	Sale	818.24	1,000	818,240	5,840	Mar 13 04:17 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Sale	928.76	220,000	204,326,151	96,016,978	Mar 04 04:00 PM
Dozier Eric	EVP, Chief People Officer	Mar 01 '25	Option Exercise	0.00	2,403	0	10,905	Mar 03 04:53 PM
Hernandez Edgardo	EVP & Pres., Mfg. Operations	Mar 01 '25	Option Exercise	0.00	2,837	0	41,009	Mar 03 04:51 PM
LILLY ENDOWMENT INC	10% Owner	Mar 03 '25	Proposed Sale	920.63	220,000	202,538,600		Mar 03 03:34 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Sale	903.07	225,000	203,190,794	96,236,978	Feb 26 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 24 '25	Sale	883.97	60,432	53,419,955	96,461,978	Feb 25 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 25 '25	Proposed Sale	881.40	225,000	198,315,000		Feb 25 03:05 PM
LILLY ENDOWMENT INC	10% Owner	Feb 21 '25	Sale	882.70	99,452	87,786,505	96,522,410	Feb 24 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 20 '25	Sale	877.99	14,685	12,893,353	96,621,862	Feb 21 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 19 '25	Sale	878.45	9,985	8,771,285	96,636,547	Feb 20 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Sale	879.52	35,446	31,175,396	96,646,532	Feb 14 04:00 PM
LILLY ENDOWMENT INC	10% Owner	Feb 13 '25	Proposed Sale	872.97	220,000	192,053,400		Feb 13 03:43 PM

Open in Screener

ADBE

Adobe Inc

Feb 11 • 04:00PM ET

257.16

-7.51 -2.84 %

Technology • Software - Application • USA • NASD

Peers: INTU ADSK CRM CDNS ANSS MSFT SNPS ORCL PANW EA

| Held by: VTI VOO QQQ VUG IVV SPY VGT XLK QUAL IWF

Index	NDX, S&P 500	P/E	15.39	EPS (ttm)	16.71	Insider Own	0.39%	Shs Outstand	413.00M	Perf Week	-8.06%
Market Cap	105.56B	Forward P/E	9.75	EPS next Y	26.37	Insider Trans	-0.11%	Shs Float	408.89M	Perf Month	-21.51%
Enterprise Value	105.62B	PEG	0.89	EPS next Q	5.86	Inst Own	86.41%	Short Float	2.92%	Perf Quarter	-21.80%
Income	7.13B	P/S	4.44	EPS this Y	11.92%	Inst Trans	-0.36%	Short Ratio	2.60	Perf Half Y	-24.01%
Sales	23.77B	P/B	9.14	EPS next Y	12.54%	ROA	23.88%	Short Interest	11.94M	Perf YTD	-26.52%
Book/sh	28.14	P/C	16.01	EPS next 5Y	10.99%	ROE	55.43%	52W High	465.70 -44.78%	Perf Year	-43.95%
Cash/sh	16.07	P/FCF	10.72	EPS past 3/5Y	18.25% 9.04%	ROIC	39.19%	52W Low	262.95 -2.20%	Perf 3Y	-30.68%
Dividend Est.	-	EV/EBITDA	11.09	Sales past 3/5Y	10.89% 13.06%	Gross Margin	88.60%	Volatility	3.39% 3.07%	Perf 5Y	-48.22%
Dividend TTM	-	EV/Sales	4.44	EPS Y/Y TTM	34.24%	Oper. Margin	36.63%	ATR (14)	9.75	Perf 10Y	243.15%
Dividend Ex-Date	Mar 24, 2005	Quick Ratio	0.97	Sales Y/Y TTM	10.53%	Profit Margin	30.00%	RSI (14)	22.83	Recom	2.17
Dividend Gr. 3/5Y	- -	Current Ratio	0.97	EPS Q/Q	17.15%	SMA20	-10.52%	Beta	1.52	Target Price	411.20
Payout	0.00%	Debt/Eq	0.57	Sales Q/Q	10.49%	SMA50	-19.72%	Rel Volume	1.68	Prev Close	264.67
Employees	31360	LT Debt/Eq	0.57	Earnings	Dec 10 AMC	SMA200	-27.16%	Avg Volume	4.60M	Price	257.16
IPO	Aug 13, 1986	Option/Short	Yes / Yes	EPS/Sales Surpr.	1.88% 1.37%	Trades		Volume	7,709,425	Change	-2.84%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-03-26	Downgrade	Piper Sandler	Overweight → Neutral	$330
Jan-13-26	Downgrade	Oppenheimer	Outperform → Perform
Jan-12-26	Resumed	Goldman	Sell	$290
Jan-09-26	Downgrade	BMO Capital Markets	Outperform → Market Perform	$375
Jan-05-26	Downgrade	Jefferies	Buy → Hold	$400
Dec-15-25	Reiterated	BMO Capital Markets	Outperform	$405 → $400
Dec-15-25	Downgrade	KeyBanc Capital Markets	Sector Weight → Underweight	$310
Sep-24-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$450
Sep-12-25	Reiterated	BMO Capital Markets	Outperform	$450 → $405
Aug-11-25	Downgrade	Melius	Hold → Sell	$310
Jul-02-25	Downgrade	Rothschild & Co Redburn	Neutral → Sell	$280
Apr-16-25	Reiterated	BMO Capital Markets	Outperform	$495 → $450
Apr-14-25	Reiterated	RBC Capital Mkts	Outperform	$530 → $480
Mar-21-25	Upgrade	KeyBanc Capital Markets	Underweight → Sector Weight
Mar-13-25	Reiterated	BMO Capital Markets	Outperform	$515 → $495
Feb-19-25	Initiated	Redburn Atlantic	Neutral
Jan-15-25	Upgrade	Exane BNP Paribas	Underperform → Neutral	$425
Jan-08-25	Downgrade	Deutsche Bank	Buy → Hold	$600 → $475
Dec-12-24	Downgrade	TD Cowen	Buy → Hold	$625 → $550
Dec-06-24	Reiterated	BMO Capital Markets	Outperform	$580 → $600

Show Previous Ratings

Today 07:30PM	Analyzing the Evolving Earnings Picture: What Should Investors Know? (Zacks)
05:45PM	Adobe Systems (ADBE) Falls More Steeply Than Broader Market: What Investors Need to Know (Zacks)
11:26AM	Oracle, Adobe Face AI Fear Pressure (GuruFocus.com)
11:23AM	Stocks Turn Mixed as Software Stocks Slide (Barchart)
09:45AM	Here's Why Adobe Systems (ADBE) is a Strong Growth Stock (Zacks)
07:19AM	Loading…
07:19AM	Oracle, Adobe in Spotlight as BNP Paribas Breaks Down Software Sell Off (GuruFocus.com)
03:53AM	Zacks.com featured highlights include Adobe, Goldman Sachs and Entergy (Zacks)
Feb-10-26 01:18PM	Salesforce and 10 More Stocks That Have Cratered and Look Like Buys (Barrons.com)
09:40AM	Why Adobe Systems (ADBE) is a Top Value Stock for the Long-Term (Zacks)
Feb-09-26 03:00PM	3 Best Earnings Acceleration Stocks to Watch for February 2026 (Zacks)
02:42PM	2 Subscription Economy Winners That Still Dominate Their Niches (MarketBeat)
02:22PM	11 Stocks That Have Cratered and Look Like Buys (Barrons.com)
12:31PM	ZETA Loses 22% in a Year: Should You Buy, Sell or Hold the Stock? (Zacks)
Feb-08-26 08:31AM	Trump Ally Mullin Buys 10 Stocks, Including These $5 Billion Companies You've Probably Never Heard Of (Benzinga)
Feb-07-26 07:30AM	Software stocks have been crushed. Here's how to play the sector as the dust settles. (MarketWatch)
07:03AM	Loading…
07:03AM	Old favorite software stocks take beating as fear of AI's impact grows (Detroit Free Press)
Feb-06-26 08:37AM	Adobe Stock: Analyst Estimates & Ratings (Barchart)
08:23AM	SEMrush Stockholders Approve Adobe Acquisition Deal at Special Meeting, Back Merger Pay Plan (MarketBeat)
Feb-05-26 07:31PM	Trump Ally Mullin Buys 10 Stocks, Including These $5 Billion Companies You've Probably Never Heard Of (Benzinga)
03:45PM	Adobe (ADBE) Stock Trades Down, Here Is Why (StockStory)
10:03AM	Zacks Earnings Trends Highlights: Gartner, Adobe and Accenture (Zacks)
08:53AM	Software ate the world. Now, Wall Street is worried AI will eat software. (MarketWatch)
05:30AM	Traders Pile Into Tech Hedges as Rout in Software Stocks Deepens (Bloomberg)
03:50AM	Figma Employees Watch 80% Of Wealth Vanish Behind 180-Day Lock-Up (Benzinga)
Feb-04-26 10:33PM	Salesforce stock gets brutal reality check amid software slump (TheStreet)
07:20PM	Earnings Outlook Improves: A Closer Look (Zacks)
05:45PM	Adobe Systems (ADBE) Increases Despite Market Slip: Here's What You Need to Know (Zacks)
05:28PM	Stocks to Watch Wednesday Recap: AMD, Super Micro, Chipotle (The Wall Street Journal)
04:15PM	AI 'coming for' software firms? Market expert explains investor fears (Reuters Videos)
02:19PM	Adobe Inc. (ADBE): A Bull Case Theory (Insider Monkey)
01:44PM	Loading…
01:44PM	From AI Darlings To Bargains: 5 Tech Stocks Near Covid-Era Valuations (Benzinga)
01:26PM	Do Stock Sell-Offs Pay Off? These Experts Warn Not to Bottom Feed on New Lows (Investopedia)
11:49AM	AI Won't Kill the Software Business, Just Its Growth Story (The Wall Street Journal)
11:26AM	Bitcoin's correlation with troubled software stock sector is growing (CoinDesk)
10:28AM	Software stocks take hit on AI. Is Wall Street worried of a bubble? (Yahoo Finance Video)
10:10AM	Software Stocks Slide Again as AI Threats Rattle Investors (Bloomberg)
10:03AM	Stocks Mixed on Sector Rotation out of Tech (Barchart)
09:39AM	Software Stocks Were Falling From Favor Even Before Tuesday's Selloff (The Wall Street Journal)
09:37AM	Company News for Feb 4, 2026 (Zacks)
08:50AM	Is the Selloff in Software Stocks Over? (The Wall Street Journal)
07:23AM	Shares dip as Anthropic update hits software stocks; gold glitters (Reuters Videos)
07:06AM	Global software stocks hit by Anthropic wake-up call on AI disruption (Reuters)
05:58AM	Stocks to Watch Wednesday: AMD, Super Micro, Chipotle (The Wall Street Journal)
04:14AM	Software 'SaaSpocalypse:' BTIG Sees Salesforce, ServiceNow Rebound, But jim Cramer Warns Of Permanent AI Obsolescence (Benzinga)
03:26AM	Heard on the Street Tuesday Recap: Code Red (The Wall Street Journal)
Feb-03-26 11:09PM	US futures mixed early as tech sector stabilizes after another massive sell-off (Associated Press Finance) -7.31%
08:16PM	Tech Stocks Are Not Always The Answer to Big Gains (Zacks)
05:44PM	Threat of New AI Tools Wipes $300 Billion Off Software and Data Stocks (The Wall Street Journal)
05:14PM	Heard on the Street Recap: Code Red (The Wall Street Journal)
05:13PM	Software Stocks Have Gotten Crushed. This Chart Says Its Not Time to Buy Yet. (Barrons.com)
04:26PM	Stocks Tumble on AI Disruption Fears (Barchart)
03:46PM	AI Disruption Fears Roil Software Industry, and the Stock Market (The Wall Street Journal)
02:51PM	Why Adobe (ADBE) Stock Is Falling Today (StockStory)
02:35PM	8 Software Stocks to Buy That Are Actually Profitable-and Cheap (Barrons.com)
01:51PM	Software Is Dying; Long Live The Bots? (Benzinga)
12:53PM	Bitcoin nears weekend low of $74,600 as stock selloff adds to crypto's woes (CoinDesk)
11:14AM	Software Stocks Retreat and Drag the Broader Market Lower (Barchart)
09:34AM	Adobe downgraded, Palantir upgraded: Wall Street's top analyst calls (The Fly)
08:00AM	Here Are Tuesdays Top Wall Street Analyst Research Calls: Adobe, Disney, Exxon Mobil, Lockheed Martin, Mastercard, Palantir Technologies, SoFi Technologies, and More (24/7 Wall St.)
07:55AM	Adobe (ADBE) Tightens Executive Pay as Analysts Cut Rating (Insider Monkey)
06:55AM	UBS, Baird Lower PT on Adobe (ADBE), BMO Capital Downgrades to Market Perform (Insider Monkey)
06:55AM	Get Me Out: Traders Dump Software Stocks as AI Fears Take Hold (Bloomberg)
Feb-02-26 09:00AM	Is Trending Stock Adobe Inc. (ADBE) a Buy Now? (Zacks)
07:04AM	What CFOs at Adobe, Dataminr, and Huntington say about scaling AI (Fortune)
Feb-01-26 04:07PM	Better Creative Tools Stock: Figma vs. Adobe (Motley Fool)
01:26PM	Baird Slashes Adobe (ADB) PT to $350 Amid AI Competition, Growth Hurdles (Insider Monkey)
12:54PM	Adobe Inc. (ADBE) a Moderate Buy, Analysts See 52% Upside (Insider Monkey)
02:38AM	Wall Street Maintains a Positive Outlook on ?Adobe Inc. (ADBE) (Insider Monkey)
Jan-30-26 01:31PM	ServiceNow Slump Highlights Software Stock Challenges in the Age of AI (Barrons.com)
Jan-29-26 05:45PM	Adobe Systems (ADBE) Dips More Than Broader Market: What You Should Know (Zacks)
04:50PM	ServiceNow Earnings Beat Estimates. Why the Software Stock Is Tumbling. (Barrons.com)
10:57AM	Microsoft Q2 Earnings Beat Estimates as Cloud and AI Drive Results (Zacks)
10:10AM	US software stocks slump as AI disruption fears take over (Reuters)
08:56AM	Software stocks fall premarket as Microsoft and SAP results weigh (Investing.com)
07:55AM	ServiceNow Stock Tumbles After Strong Earnings. Here's Why. (Barrons.com)
04:50AM	Better AI Software Stock: Figma vs. Adobe (Motley Fool)
03:49AM	LinkedIn Says Employers 'Want To Know What You Can Actually Do' As It Rolls Out Verified AI Skills (Benzinga)
Jan-28-26 04:13PM	ServiceNow stock falls despite earnings beat as CEO Bill McDermott tries to get investors to stop thinking of it as a SaaS company (Fortune)
12:17PM	Goldman, BMO, and Jefferies Downgrade Adobe (ADBE) (Insider Monkey)
09:52AM	"I Don't Know What to do With Adobe (ADBE)," Says Jim Cramer (Insider Monkey)
Jan-27-26 09:00AM	Node-based design tool Flora raises $42M from Redpoint Ventures (TechCrunch)
08:02AM	CRM vs. ADBE: Which Enterprise Software Stock Is the Better Buy? (Zacks)
Jan-26-26 02:49PM	Figma's IPO Is a Cautionary Tale. How AI Busted the Stock. (Barrons.com)
06:02AM	1 AI Stock Down 14% to Start 2026 That Looks Like an Absolute Bargain Right Now (Motley Fool)
04:19AM	Zacks Market Edge Highlights: Twilio, Salesforce and Adobe (Zacks)
12:01AM	Anthropics Claude Code Platform Looks Like a Software Killer (The Daily Upside)
Jan-25-26 06:20PM	This founder cracked firefighting now hes creating an AI gold mine (TechCrunch)
05:30AM	Wall Street Has Fallen Out of Love With Software Stocks (The Wall Street Journal)
Jan-23-26 01:54PM	After a 32% Reckoning In Shares, Investors Are Calling The Salesforce Bottom. Its Time To Rally \| CRM (24/7 Wall St.)
10:47AM	Software Stocks Have Plunged: Steals or Traps? (Zacks)
02:04AM	Earnings Preview: What To Expect From Adobe's Report (Barchart)
Jan-22-26 05:45PM	Adobe Systems (ADBE) Beats Stock Market Upswing: What Investors Need to Know (Zacks)
04:41PM	Adobe Partners With Hollywood Players On Generative AI (Investor's Business Daily)
03:20PM	The Real Reason Markets Hate This Cheap Stock Right Now (Motley Fool)
01:50PM	Is This Beaten-Down Tech Stock a Once-in-a-Decade Opportunity? (Motley Fool)
12:37PM	Adobe's Digital Media Revenues Gain Traction: What's the Path Ahead? (Zacks)
06:48AM	Jim Cramer Reveals Why He Might Cancel His Adobe (ADBE) Subscription (Insider Monkey)
06:01AM	Why 'Cheap' Software Stocks Could Be The Next Big AI Value Trap (Benzinga)
Jan-21-26 12:07PM	ServiceNow vs. Adobe: Which Cloud Software Stock Has an Edge Now? (Zacks)
11:23AM	Adobe nabs CIO from Airbnb (CIO Dive)

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Chen Gloria	EVP, Chief People Officer	Jan 24 '26	Option Exercise	0.00	10,663	0	52,017	Jan 27 07:09 PM
Wadhwani David	President, C&P	Jan 24 '26	Option Exercise	0.00	24,213	0	51,316	Jan 27 07:08 PM
NARAYEN SHANTANU	Chair and CEO	Jan 24 '26	Option Exercise	0.00	69,553	0	464,213	Jan 27 07:08 PM
Forusz Jillian	SVP & CAO	Jan 24 '26	Option Exercise	0.00	559	0	3,726	Jan 27 07:08 PM
Chakravarthy Anil	President, CXO	Jan 24 '26	Option Exercise	0.00	24,213	0	70,468	Jan 27 07:07 PM
Durn Daniel	EVP & CFO	Jan 24 '26	Option Exercise	0.00	15,660	0	51,520	Jan 27 07:07 PM
Durn Daniel	EVP & CFO	Jan 27 '26	Sale	294.85	1,646	485,323	41,995	Jan 27 07:07 PM
Durn Daniel	Officer	Jan 27 '26	Proposed Sale	294.85	1,646	485,323		Jan 27 03:57 PM
Chen Gloria	EVP, Chief People Officer	Jan 15 '26	Option Exercise	0.00	1,938	0	41,750	Jan 16 06:26 PM
Chakravarthy Anil	President, CXO	Jan 15 '26	Option Exercise	0.00	1,895	0	46,900	Jan 16 06:26 PM
Durn Daniel	EVP & CFO	Jan 15 '26	Option Exercise	0.00	2,833	0	36,727	Jan 16 06:26 PM
NARAYEN SHANTANU	Chair and CEO	Jan 15 '26	Option Exercise	0.00	5,443	0	396,262	Jan 16 06:26 PM
Forusz Jillian	SVP & CAO	Jan 15 '26	Option Exercise	0.00	117	0	3,188	Jan 16 06:25 PM
Wadhwani David	President, C&P	Jan 15 '26	Option Exercise	0.00	1,895	0	27,552	Jan 16 06:25 PM
Balazs Lara	Chief Marketing Officer & EVP	Jan 15 '26	Option Exercise	0.00	4,919	0	4,978	Jan 16 06:24 PM
Forusz Jillian	SVP & CAO	Dec 15 '25	Option Exercise	0.00	461	0	3,771	Dec 16 04:34 PM
Forusz Jillian	SVP & CAO	Oct 31 '25	Sale	337.88	149	50,344	3,426	Nov 04 05:02 PM
JILLIAN FORUSZ	Officer	Oct 31 '25	Proposed Sale	337.88	149	50,344		Oct 31 04:32 PM
Durn Daniel	EVP & CFO	Oct 24 '25	Option Exercise	0.00	606	0	35,170	Oct 27 05:06 PM
Forusz Jillian	SVP & CAO	Oct 24 '25	Option Exercise	0.00	30	0	3,589	Oct 27 05:06 PM
NARAYEN SHANTANU	Chair and CEO	Oct 24 '25	Option Exercise	0.00	1,254	0	393,175	Oct 27 05:06 PM
Wadhwani David	President, Digital Media	Oct 24 '25	Option Exercise	0.00	606	0	26,400	Oct 27 05:05 PM
Chen Gloria	EVP, Chief People Officer	Oct 24 '25	Option Exercise	0.00	424	0	40,473	Oct 27 05:05 PM
Chakravarthy Anil	President, DX	Oct 24 '25	Option Exercise	0.00	606	0	45,928	Oct 27 05:05 PM
Chakravarthy Anil	President, DX	Oct 15 '25	Option Exercise	0.00	1,892	0	45,666	Oct 16 04:37 PM
Durn Daniel	EVP & CFO	Oct 15 '25	Option Exercise	0.00	2,832	0	35,113	Oct 16 04:37 PM
Forusz Jillian	SVP & CAO	Oct 15 '25	Option Exercise	0.00	116	0	3,569	Oct 16 04:37 PM
Wadhwani David	President, Digital Media	Oct 15 '25	Option Exercise	0.00	1,892	0	26,138	Oct 16 04:36 PM
NARAYEN SHANTANU	Chair and CEO	Oct 15 '25	Option Exercise	0.00	5,442	0	392,901	Oct 16 04:35 PM
Chen Gloria	EVP, Chief People Officer	Oct 15 '25	Option Exercise	0.00	1,935	0	40,407	Oct 16 04:35 PM
Forusz Jillian	SVP & CAO	Sep 15 '25	Option Exercise	0.00	460	0	3,610	Sep 17 05:13 PM
NARAYEN SHANTANU	Chair and CEO	Jul 24 '25	Option Exercise	0.00	1,254	0	389,796	Jul 28 05:07 PM
Wadhwani David	President, Digital Media	Jul 24 '25	Option Exercise	0.00	606	0	25,138	Jul 28 05:07 PM
Durn Daniel	EVP & CFO	Jul 24 '25	Option Exercise	0.00	606	0	33,530	Jul 28 05:06 PM
Chen Gloria	EVP, Chief People Officer	Jul 24 '25	Option Exercise	0.00	424	0	39,282	Jul 28 05:06 PM
Chakravarthy Anil	President, DX	Jul 24 '25	Option Exercise	0.00	606	0	44,666	Jul 28 05:05 PM
Forusz Jillian	SVP & CAO	Jul 24 '25	Option Exercise	0.00	30	0	3,279	Jul 28 04:39 PM
Chakravarthy Anil	President, DX	Jul 15 '25	Option Exercise	0.00	1,894	0	44,405	Jul 17 04:50 PM
Chen Gloria	EVP, Chief People Officer	Jul 15 '25	Option Exercise	0.00	1,938	0	39,217	Jul 17 04:48 PM
Durn Daniel	EVP & CFO	Jul 15 '25	Option Exercise	0.00	2,833	0	33,474	Jul 17 04:47 PM
Wadhwani David	President, Digital Media	Jul 15 '25	Option Exercise	0.00	1,894	0	24,877	Jul 17 04:45 PM
NARAYEN SHANTANU	Chair and CEO	Jul 15 '25	Option Exercise	0.00	5,443	0	389,522	Jul 17 04:43 PM
Forusz Jillian	SVP & CAO	Jul 15 '25	Option Exercise	0.00	117	0	3,259	Jul 17 04:41 PM
Wadhwani David	President, Digital Media	Jun 14 '25	Option Exercise	0.00	1,933	0	24,477	Jun 16 05:48 PM
Forusz Jillian	SVP & CAO	Jun 15 '25	Option Exercise	0.00	460	0	3,214	Jun 16 05:48 PM
Forusz Jillian	SVP & CAO	May 02 '25	Sale	380.58	462	175,828	2,834	May 06 04:14 PM
Forusz Jillian	Officer	May 02 '25	Proposed Sale	380.58	462	175,828		May 02 04:31 PM
Chakravarthy Anil	President, DX	Apr 24 '25	Option Exercise	0.00	606	0	43,347	Apr 28 04:35 PM
Durn Daniel	EVP & CFO	Apr 24 '25	Option Exercise	0.00	606	0	31,833	Apr 28 04:29 PM
Forusz Jillian	SVP & CAO	Apr 24 '25	Option Exercise	0.00	30	0	3,306	Apr 28 04:29 PM
NARAYEN SHANTANU	Chair and CEO	Apr 24 '25	Option Exercise	0.00	1,254	0	386,417	Apr 28 04:29 PM
Wadhwani David	President, Digital Media	Apr 24 '25	Option Exercise	0.00	606	0	22,844	Apr 28 04:28 PM
Chen Gloria	EVP, Chief People Officer	Apr 24 '25	Option Exercise	0.00	424	0	38,032	Apr 28 04:28 PM
AMON CRISTIANO R	Director	Apr 22 '25	Option Exercise	0.00	633	0	922	Apr 23 06:56 PM
Banse Amy	Director	Apr 22 '25	Option Exercise	0.00	633	0	33,562	Apr 23 06:56 PM
Boulden Melanie	Director	Apr 22 '25	Option Exercise	0.00	633	0	3,065	Apr 23 06:55 PM
CALDERONI FRANK	Director	Apr 22 '25	Option Exercise	0.00	633	0	31,817	Apr 23 06:55 PM
Neumann Spencer Adam	Director	Apr 22 '25	Option Exercise	0.00	633	0	2,278	Apr 23 06:55 PM
Oberg Kathleen K.	Director	Apr 22 '25	Option Exercise	0.00	633	0	4,350	Apr 23 06:55 PM
Pandey Dheeraj	Director	Apr 22 '25	Option Exercise	0.00	633	0	5,020	Apr 23 06:55 PM
ROSENSWEIG DANIEL	Director	Apr 22 '25	Option Exercise	0.00	633	0	5,006	Apr 23 06:55 PM
Ricks David A	Director	Apr 22 '25	Option Exercise	0.00	633	0	5,617	Apr 23 06:54 PM
Desmond Laura	Director	Apr 22 '25	Option Exercise	0.00	633	0	31,733	Apr 23 06:54 PM
Biggs M. Brett	Director	Apr 22 '25	Option Exercise	0.00	633	0	2,278	Apr 23 06:54 PM
Wadhwani David	President, Digital Media	Apr 15 '25	Option Exercise	0.00	1,892	0	22,582	Apr 17 07:30 PM
NARAYEN SHANTANU	Chair and CEO	Apr 15 '25	Option Exercise	0.00	5,440	0	386,143	Apr 17 07:30 PM
Forusz Jillian	SVP & CAO	Apr 15 '25	Option Exercise	0.00	114	0	3,283	Apr 17 07:29 PM
Durn Daniel	EVP & CFO	Apr 15 '25	Option Exercise	0.00	2,832	0	31,776	Apr 17 07:29 PM
Chen Gloria	EVP, Chief People Officer	Apr 15 '25	Option Exercise	0.00	1,935	0	37,966	Apr 17 07:29 PM
Chakravarthy Anil	President, DX	Apr 15 '25	Option Exercise	0.00	1,892	0	43,085	Apr 17 07:28 PM
Belsky Scott	Officer	Apr 01 '25	Proposed Sale	383.00	5,012	1,919,596		Apr 01 05:37 PM
Durn Daniel	EVP & CFO	Mar 20 '25	Buy	390.58	1,300	507,758	29,876	Mar 21 04:34 PM
Forusz Jillian	SVP & CAO	Mar 15 '25	Option Exercise	0.00	785	0	3,278	Mar 17 05:57 PM
Wadhwani David	President, Digital Media	Mar 14 '25	Option Exercise	0.00	1,933	0	22,240	Mar 17 05:57 PM

LLY

Lilly(Eli) & Co

ADBE

Adobe Inc

Upgrade your FINVIZ experience